Valuation
- Market cap
- —
- Revenue TTM
- $0
- Net income TTM
- $0
- P/E (trailing)
- —
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- —
Trading
- Volume
- 5,000
- Avg volume
- 10,634
- Day's range
- $0.08 – $0.08
- Shares out
- —
- Stochastic %K
- 63%
- Beta
- —
- Analysts
- —
- Price target
- —
Company profile
SureNano Science Ltd. engages in the distribution and sale of surfactant in Canada and the United States. It provides SureNano surfactant, a ready-to-mix food-grade compound that provides the base for high performance nano-emulsions to create homogeneous and stable products. The company was incorporated in 2021 and is headquartered in Vancouver, Canada.
- Industry
- Specialty Chemicals
- Sector
- Basic Materials
- Phone
- 604 428 5171
- Website
- https://www.surenano.com
- Address
- 800 West Pender Street, Suite 1500, Vancouver, Canada
Latest news
No headlines yet.
Stocktwits
QuietlyAccumulating
Oct 10, 2:01 AM
$SURNF Making progress on a next generation of glp-1 without the concerning side effects, becoming more and more evident with current forms of this medication.
0 replies
NetworkNewsWire
Jun 11, 6:50 PM
InvestorNewsBreaks –
$SURE.CN
$SURNF Accelerates Development Strategy for Lead Candidate https://ibn.fm/bsN3Z
NetworkNewsWire
May 21, 5:03 PM
BioMedNewsBreaks — Why
$SURE.CN
$SURNF Is ‘One to Watch’ https://ibn.fm/Z7Cze
NetworkNewsWire
May 15, 7:21 PM
NetworkNewsBreaks –
$SURE.CN
$SURNF Featured in NetworkNewsAudio Editorial on Next-Generation GLP-1 Therapies https://ibn.fm/27AXg
NetworkNewsWire
May 13, 5:10 PM
InvestorNewsBreaks –
$SURE.CN
$SURNF Featured in BioMedWire Editorial on Next-Generation GLP-1 Innovation https://ibn.fm/piImt
NetworkNewsWire
May 13, 1:19 PM
Next-Generation GLP-1 Innovation Could Unlock Massive Metabolic Healthcare Market Opportunities
$SURE.CN
$SURNF $MRK $ABBV $VKTX $ALT https://ibn.fm/xuvoa
NetworkNewsWire
May 12, 3:53 PM
BioMedNewsBreaks —
$SURE.CN
$SURNF Featured in BioMedWire Editorial on Next-Generation GLP-1 Innovation https://ibn.fm/sv4Fw
